RecruitingNCT06280755

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study

Sponsor

icometrix

Enrollment

7,000 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis Clinically Isolated Syndrome NMO Spectrum Disorder Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Radiologically Isolated Syndrome

Summary

The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a retrospective (looking back at past data) observational study that uses AI to analyze medical records from patients with multiple sclerosis (MS) and related conditions. The goal is to evaluate whether AI-assisted tools can improve how doctors monitor and manage MS care. **You may be eligible if...** - You have a confirmed diagnosis of MS, NMOSD (neuromyelitis optica spectrum disorder), MOGAD, clinically isolated syndrome (CIS), or radiologically isolated syndrome (RIS) - You (or your legal representative) have previously signed consent allowing use of your data for research, OR the study has ethics committee approval to use your data without individual consent **You may NOT be eligible if...** - You are under 18 years old - Your data is insufficient for meaningful analysis, at the investigator's discretion Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(3)

General University Hospital Prague

Prague, Praha 2, Czechia

Katholisches Klinikum Bochum - St. Joseph-Hospital

Bochum, Bochum, Germany

ERC Charité - Universitätsmedizin Berlin

Berlin, State of Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06280755

Related Trials

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

NCT027842101 location

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT000012481 location

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

NCT058494671 location

Blood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)

NCT067952301 location